Biolife Sciences (Biolife Sciences) Other Long-Term Liabilities : $0.00 Mil (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Other Long-Term Liabilities?

Biolife Sciences's other long-term liabilities for the quarter that ended in May. 2008 was $0.00 Mil.

Biolife Sciences's quarterly other long-term liabilities declined from Nov. 2007 ($-0.00 Mil) to Feb. 2008 ($-0.00 Mil) but then increased from Feb. 2008 ($-0.00 Mil) to May. 2008 ($0.00 Mil).

Biolife Sciences's annual other long-term liabilities declined from Nov. 2005 ($0.02 Mil) to Nov. 2006 ($-0.00 Mil) but then increased from Nov. 2006 ($-0.00 Mil) to Nov. 2007 ($-0.00 Mil).

Biolife Sciences Other Long-Term Liabilities Historical Data

The historical data trend for Biolife Sciences's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Other Long-Term Liabilities Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Other Long-Term Liabilities

Biolife Sciences Quarterly Data
	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Other Long-Term Liabilities	Get a 7-Day Free Trial									-	-	-	-	-

Biolife Sciences Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Biolife Sciences Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020